Vascular Stents Market - Global Forecast to 2029
| 出版社 | MarketsandMarkets |
| 出版年月 | 2024年9月 |
| ページ数 | 427 |
| 図表数 | 673 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
Report Overview
The global vascular stent market is projected to reach USD 15.6 billion by 2029 from USD 11.4 billion in 2024, at a CAGR of 6.5% from 2024 to 2029.
世界の血管ステント市場は、2024年から2029年までCAGR 6.5%で、2024年の114億ドルから2029年までに156億ドルに達すると予測されています。
The growth of the market is driven by increase in acquisitions by major players, increase in adoption of minimally invasive procedures. However, availability of alternative treatment methods to treat vascular disease, is impacting the growth of the market. Moreover, the product recalls and failures in the field of vascular stent are a major factor restraining the market growth.
“Polymer segment to witness the significant growth during the forecast period.”
Based on material, the segment is divided into metallic material, and polymer material. The polymer segment is further divided into biodegradable polymers and non-biodegradable polymers. In 2023, among these two polymers, the biodegradable polymer segment to witness the highest growth in vascular stent market. Because of their prospective medicinal uses, biodegradable polymers are expected to witness significant expansion in the vascular stent market. These polymers, which are essential for drug-eluting stent (DES) platforms, guarantee the antiproliferative medications’ optimum release, leading to the best possible DES performance. Compared to permanent polymers, biodegradable polymers can reduce chronic inflammation of the arterial wall, hence reducing the risk of late restenosis and stent thrombosis. Clinical experiments have demonstrated that biodegradable polymer DES platforms function similarly to permanent polymer DES platforms during the first year of implantation, with longer-term follow-ups revealing encouragingly lower rates of stent thrombosis. The promise to increase patient safety and efficacy is what motivates their planned market expansion.
“Peripheral segment accounted for the significant growth in the vascular stent market during the forecast period.”
Based on product, the vascular stent market is segmented into coronary stents, peripheral stents, and EVAR stent grafts. Among these in 2023, peripheral stents accounted for significant share. Throughout the projected period, peripheral stents are anticipated to have substantial growth in the vascular stent market, driven by the increased prevalence of peripheral vascular illnesses, especially in the aging population. The American Heart Association revealed in June 2023 that 200 million people worldwide and approximately 12 million Americans suffer with peripheral vascular disease (PAD). This rising prevalence highlights the need for efficient treatment alternatives such as Stents for the periphery. Additionally, developments in biodegradable polymer stents provide a more patient-centered, minimally invasive approachable substitute, increasing their uptake and market expansion even more.
“APAC is estimated to register the highest CAGR during the forecast period.”
In this report, the vascular stent market is segmented into five major regional segments, namely, North America, Europe, Asia Pacific, Latin America and Middle East and Africa. During the forecast period, the Asia Pacific region is anticipated to experience the largest growth in the vascular stent market by material, mainly because of the increasingly aging population that is causing an increase in the frequency of cardiovascular illnesses. As of June 2022, the population of Asia and the Pacific is aging at a rate faster than any other region in the world, with 630 million people in the region making up 60% of the world’s senior population, according to the Economic and Social Commission for Asia and the Pacific. By 2050, it is anticipated that this number would increase to 1.3 billion, greatly increasing the need for vascular stents to treat age-related cardiovascular diseases and propelling market expansion.
Breakdown of supply-side primary interviews, by company type, designation, and region:
- By Company Type: Tier 1 (20%), Tier 2 (45%), and Tier 3 (35%)
- By Designation: C-level (30%), Director-level (20%), and Others (50%)
- By Region: North America (35%), Europe (24%), Asia Pacific (25%), RoW (16%)
List of Companies Profiled in the Report
o Medtronic Plc (Ireland)
o Abbott Laboratories (US)
o Boston Scientific Corporation (US)
o B Braun SE (Germany)
o Terumo Corporation (Japan)
o Biotronik SE & Co.KG (Germany)
o Shanghai Microport Medical (Group) Co., Ltd (China)
o Meril Life Science Pvt. Ltd (India)
o Sahajanan Medical Technologies Limited (India)
o Becton, Dickinson, and Company (US)
o W.L. Gore & Associates, Inc (US)
o Cordis Corporation (US)
o Artivion Inc (US)
o Stryker Corporation (US)
o LifeTech Scientific Corporation (China)
o Translumina (Germany)
o Lepu Medical Technology (Beijing) Co., Ltd (China)
o Endologix LLC. (US)
o Biosensors International Group, Ltd (Singapore)
o Cook Medical (US)
o Insitu Technologies Inc (US)
o iVascular (Spain)
o OrbusNeich Medical Group Holdings Limited (China)
o Alvimedica (Turkey).
o Elixir Medical (US)
Research Coverage
This report studies the vascular stent market based on product, procedure, technology, application, end user and region. The report also analyses factors (such as drivers, restraints, opportunities and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the total vascular stent market. The report forecasts the revenue of the market segments with respect to five major regions.
Reasons to Buy the Report
This report also includes.
- Analysis of key drivers (rising incidence of vascular diseases and growth in number of angioplasty procedures, advancements in stent technology and materials, increase in adoption of minimally invasive procedures),restraints (Availability of alternative treatment methods for vascular diseases, stringent regulations for product approval, product failures and recalls), challenges (High risk of complications, declining cost of stent), opportunities (Development of bioresorbable vascular scaffold stent, emerging markets to offer high-growth opportunities for market participants, increase in aging population) contributing the growth of the vascular stent market.
- Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new software launches in the vascular stent market.
- Market Development: Comprehensive information on the lucrative emerging markets, technology, product, mode of delivery, material, end-user and region.
- Market Diversification: Exhaustive information about the growing geographies, recent developments, investments in the vascular stent market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global vascular stent market.
Table of Contents
1 INTRODUCTION 37
1.1 STUDY OBJECTIVES 37
1.2 MARKET DEFINITION 37
1.3 MARKET SCOPE 38
1.3.1 MARKETS COVERED 38
1.3.2 INCLUSIONS & EXCLUSIONS 39
1.3.3 YEARS CONSIDERED 39
1.3.4 CURRENCY CONSIDERED 40
1.4 MARKET STAKEHOLDERS 40
1.5 SUMMARY OF CHANGES 40
2 RESEARCH METHODOLOGY 42
2.1 RESEARCH DATA 42
2.1.1 SECONDARY DATA 43
2.1.1.1 Key data from secondary sources 44
2.1.2 PRIMARY DATA 44
2.1.2.1 Key data from primary sources 46
2.1.2.2 Key industry insights 47
2.2 MARKET SIZE ESTIMATION 48
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 53
2.4 MARKET RANKING ANALYSIS 53
2.5 STUDY ASSUMPTIONS 54
2.6 RESEARCH LIMITATIONS 54
2.6.1 METHODOLOGY-RELATED LIMITATIONS 54
2.6.2 SCOPE-RELATED LIMITATIONS 54
2.7 RISK ASSESSMENT 55
3 EXECUTIVE SUMMARY 56
4 PREMIUM INSIGHTS 62
4.1 VASCULAR STENTS MARKET OVERVIEW 62
4.2 NORTH AMERICA: VASCULAR STENTS MARKET, BY PRODUCT 63
4.3 GEOGRAPHIC SNAPSHOT OF VASCULAR STENTS MARKET 64
4.4 VASCULAR STENTS MARKET: REGIONAL MIX, 2024–2029 (USD MILLION) 65
5 MARKET OVERVIEW 66
5.1 INTRODUCTION 66
5.2 MARKET DYNAMICS 66
5.2.1 DRIVERS 67
5.2.1.1 Increasing incidence of vascular diseases and subsequent rise in angioplasty procedures 67
5.2.1.2 Technological advancements in stents 67
5.2.1.3 Growing preference for minimally invasive surgeries 68
5.2.2 RESTRAINTS 68
5.2.2.1 Availability of open surgical procedures to hinder market growth 68
5.2.2.2 Stringent regulatory guidelines for product approval 68
5.2.2.3 Product failures and recalls 69
5.2.3 OPPORTUNITIES 69
5.2.3.1 Development of bioresorbable vascular scaffold stents 69
5.2.3.2 High growth potential of emerging markets 70
5.2.4 CHALLENGES 70
5.2.4.1 Complications associated with stenting procedures 70
5.2.4.2 Declining cost of stents 71
5.3 INDUSTRY TRENDS 71
5.3.1 COMBINATION THERAPIES 71
5.3.2 PERSONALIZED MEDICINE 72
5.3.3 EXPANDING APPLICATIONS 72
5.4 TECHNOLOGY ANALYSIS 72
5.4.1 KEY TECHNOLOGIES 72
5.4.1.1 3D printing 72
5.4.1.2 Electrospinning 73
5.4.1.3 Balloon-expandable stents 73
5.4.2 COMPLEMENTARY TECHNOLOGIES 73
5.4.2.1 Element simulation technology 73
5.4.2.2 Stereolithography (SLA) technology 74
5.4.2.3 Laser-cutting technology 74
5.4.3 ADJACENT TECHNOLOGIES 74
5.4.3.1 Continuous sinusoid technology 75
5.4.3.2 Micro-injection molding technology 75
5.4.3.3 Imaging technology 75
5.5 PORTER’S FIVE FORCE ANALYSIS 76
5.5.1 INTENSITY OF COMPETITIVE RIVALRY 76
5.5.2 BARGAINING POWER OF SUPPLIERS 76
5.5.3 BARGAINING POWER OF BUYERS 77
5.5.4 THREAT OF SUBSTITUTES 77
5.5.5 THREAT OF NEW ENTRANTS 77
5.6 REGULATORY LANDSCAPE 78
5.6.1 REGULATORY ANALYSIS 78
5.6.1.1 North America 78
5.6.1.1.1 US 78
5.6.1.1.2 Canada 78
5.6.1.2 Europe 78
5.6.1.3 Asia Pacific 79
5.6.1.3.1 Japan 79
5.6.1.3.2 China 79
5.6.1.4 Latin America 80
5.6.1.5 Middle East & Africa 80
5.6.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
5.7 PATENT ANALYSIS 83
5.7.1 PATENT PUBLICATION TRENDS IN VASCULAR STENTS MARKET 83
5.7.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 83
5.8 TRADE ANALYSIS 86
5.8.1 TRADE ANALYSIS FOR VASCULAR STENTS 86
5.9 PRICING ANALYSIS 87
5.10 KEY CONFERENCES & EVENTS 88
5.11 KEY STAKEHOLDERS AND BUYING CRITERIA 89
5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS 89
5.11.2 BUYING CRITERIA 89
5.12 UNMET NEEDS 90
5.13 END-USER EXPECTATIONS 91
5.14 IMPACT OF GENERATIVE AI ON VASCULAR STENTS MARKET 91
5.15 ECOSYSTEM ANALYSIS 92
5.16 CASE STUDY ANALYSIS 93
5.16.1 CASE STUDY 1: UTILIZATION OF GORE VIABAHN VBX BALLOON-EXPANDABLE STENTS FOR ANGIOGRAPHY PROCEDURE 93
5.16.2 CASE STUDY 2: SUCCESSFUL TREATMENT OF PATIENT WITH SEVERE CAROTID ARTERY STENOSIS 94
5.16.3 CASE STUDY 3: W.L. GORE UTILIZED VBX BALLOON-EXPANDABLE STENT FOR ILIAC ARTERY STENOSIS TREATMENT 95
5.17 SUPPLY CHAIN ANALYSIS 95
5.18 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 97
5.19 INVESTMENT & FUNDING SCENARIO 97
5.20 ADJACENT MARKET ANALYSIS 98
5.20.1 INTERVENTIONAL CARDIOLOGY DEVICES MARKET 98
6 VASCULAR STENT MARKET, BY TECHNOLOGY 100
6.1 INTRODUCTION 101
6.2 DRUG-ELUTING STENTS 102
6.2.1 LONG-TERM BENEFITS ASSOCIATED WITH DRUG-ELUTING STENTS TO DRIVE MARKET 102
6.3 BARE METAL STENTS 104
6.3.1 COST-EFFICIENT BENEFITS TO FUEL UPTAKE 104
6.4 COVERED STENTS 107
6.4.1 UTILIZATION IN ENDOVASCULAR REPAIR AND VASCULAR LESIONS TO DRIVE MARKET 107
6.5 BIOABSORBABLE STENTS 110
6.5.1 ABILITY TO MINIMIZE COMPLICATIONS ASSOCIATED WITH PERMANENT DEVICES TO SUPPORT MARKET GROWTH 110
7 VASCULAR STENTS MARKET, BY PRODUCT 113
7.1 INTRODUCTION 114
7.2 CORONARY STENTS 114
7.2.1 INCREASING PREVALENCE OF CORONARY ARTERY DISEASE TO PROPEL MARKET 114
7.3 PERIPHERAL STENTS 116
7.3.1 CAROTID ARTERY STENTS 119
7.3.1.1 Rapid recovery time and lower risk of myocardial ischemia to boost demand 119
7.3.2 FEMORAL ARTERY STENTS 121
7.3.2.1 Minimal incisions and shorter recovery time to fuel market 121
7.3.3 RENAL ARTERY STENTS 123
7.3.3.1 Rising incidence of hypertension and FMD to support market growth 123
7.3.4 ILIAC ARTERY STENTS 125
7.3.4.1 Increasing prevalence of atherosclerosis to fuel uptake 125
7.3.5 OTHER PERIPHERAL STENTS 127
7.4 EVAR STENT GRAFTS 129
7.4.1 ABDOMINAL AORTIC ANEURYSM STENT GRAFTS 130
7.4.1.1 Rising incidence of AAA cases to drive market 130
7.4.2 THORACIC AORTIC ANEURYSM STENT GRAFTS 132
7.4.2.1 Rising prevalence of renal artery stenosis to support market growth 132
8 VASCULAR STENTS MARKET, BY MODE OF DELIVERY 135
8.1 INTRODUCTION 136
8.2 BALLOON-EXPANDABLE STENTS 136
8.2.1 ABILITY TO TREAT CORONARY VESSEL DAMAGE TO DRIVE MARKET 136
8.3 SELF-EXPANDING STENTS 139
8.3.1 HIGH UPTAKE IN ABDOMINAL & THORACIC EVAR PROCEDURES TO PROPEL MARKET 139
9 VASCULAR STENTS MARKET, BY MATERIAL 143
9.1 INTRODUCTION 144
9.2 METALLIC MATERIALS 144
9.2.1 COBALT CHROMIUM 147
9.2.1.1 Biocompatibility properties to boost demand 147
9.2.2 PLATINUM CHROMIUM 149
9.2.2.1 Enhanced visibility and superior radial strength to support market growth 149
9.2.3 NICKEL TITANIUM 151
9.2.3.1 Growing adoption of MIS procedures to boost demand 151
9.2.4 STAINLESS STEEL 153
9.2.4.1 High reliability and cost-efficiency to boost uptake 153
9.3 POLYMERIC MATERIALS 155
9.3.1 BIODEGRADABLE POLYMERS 158
9.3.1.1 Advantages offered by biodegradable polymers to drive market 158
9.3.2 NON-BIODEGRADABLE POLYMERS 160
9.3.2.1 Inert alternative to potential inflammatory responses to support market growth 160
10 VASCULAR STENTS MARKET, BY END USER 163
10.1 INTRODUCTION 164
10.2 HOSPITALS 164
10.2.1 RISING NUMBER OF ANGIOPLASTY PROCEDURES TO FUEL MARKET 164
10.3 CARDIAC CENTERS 166
10.3.1 INCREASING CASES OF STROKE TO DRIVE MARKET 166
11 VASCULAR STENTS MARKET, BY REGION 169
11.1 INTRODUCTION 170
11.2 NORTH AMERICA 172
11.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK 173
11.2.2 US 181
11.2.2.1 Supportive regulatory policies for cardiovascular product commercialization to fuel uptake 181
11.2.3 CANADA 188
11.2.3.1 Rising incidence of peripheral artery disease to drive market 188
11.3 EUROPE 194
11.3.1 EUROPE: MACROECONOMIC OUTLOOK 195
11.3.2 GERMANY 202
11.3.2.1 Rising uptake of angioplasty procedures to fuel market 202
11.3.3 UK 209
11.3.3.1 Increasing incidence of acute coronary syndrome to propel market 209
11.3.4 FRANCE 215
11.3.4.1 Rising incidence of chronic diseases to drive market 215
11.3.5 ITALY 222
11.3.5.1 Rising cases of atherosclerotic CVD to support market growth 222
11.3.6 SPAIN 228
11.3.6.1 Increasing prevalence of obesity to boost demand 228
11.3.7 REST OF EUROPE 234
11.4 ASIA PACIFIC 241
11.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK 241
11.4.2 CHINA 250
11.4.2.1 Growing demand for peripheral artery stents to drive market 250
11.4.3 JAPAN 256
11.4.3.1 Increasing preference for PCI surgeries to drive market 256
11.4.4 INDIA 263
11.4.4.1 Improvements in healthcare policies for affordable medical devices to propel market 263
11.4.5 AUSTRALIA 270
11.4.5.1 Rising hospitalization rates due to CAD cases to drive market 270
11.4.6 SOUTH KOREA 277
11.4.6.1 Rising incidence of diabetes to boost demand 277
11.4.7 REST OF ASIA PACIFIC 283
11.5 LATIN AMERICA 290
11.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK 290
11.5.2 BRAZIL 297
11.5.2.1 Growing demand for advanced medical equipment to drive market 297
11.5.3 MEXICO 304
11.5.3.1 Increasing imports of medical devices to fuel market 304
11.5.4 REST OF LATIN AMERICA 310
11.6 MIDDLE EAST & AFRICA 317
11.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK 317
11.6.2 GCC COUNTRIES 324
11.6.2.1 Increasing prevalence of hypertension to drive market 324
11.6.3 REST OF MIDDLE EAST & AFRICA 330
12 COMPETITIVE LANDSCAPE 337
12.1 OVERVIEW 337
12.2 KEY PLAYER STRATEGY/RIGHT TO WIN 337
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN VASCULAR STENTS MARKET 337
12.3 REVENUE ANALYSIS 338
12.4 MARKET SHARE ANALYSIS 339
12.4.1 RANKING OF KEY MARKET PLAYERS 341
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 342
12.5.1 STARS 342
12.5.2 EMERGING LEADERS 342
12.5.3 PERVASIVE PLAYERS 342
12.5.4 PARTICIPANTS 342
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 344
12.5.5.1 Company footprint 344
12.5.5.2 Technology footprint 345
12.5.5.3 Product footprint 346
12.5.5.4 Mode of delivery footprint 347
12.5.5.5 Material footprint 348
12.5.5.6 End-user footprint 349
12.5.5.7 Region footprint 350
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 351
12.6.1 PROGRESSIVE COMPANIES 351
12.6.2 RESPONSIVE COMPANIES 351
12.6.3 DYNAMIC COMPANIES 351
12.6.4 STARTING BLOCKS 351
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 353
12.7 COMPANY VALUATION & FINANCIAL METRICS 354
12.7.1 FINANCIAL METRICS 354
12.7.2 COMPANY VALUATION 354
12.8 BRAND/PRODUCT COMPARISON 355
12.9 COMPETITIVE SCENARIO 356
12.9.1 PRODUCT LAUNCHES & APPROVALS 356
12.9.2 DEALS 357
12.9.3 OTHER DEVELOPMENTS 357
13 COMPANY PROFILES 358
13.1 KEY PLAYERS 358
13.1.1 MEDTRONIC PLC 358
13.1.1.1 Business overview 358
13.1.1.2 Products offered 359
13.1.1.3 Recent developments 361
13.1.1.3.1 Product approvals 361
13.1.1.4 MnM view 361
13.1.1.4.1 Key strengths 361
13.1.1.4.2 Strategic choices 362
13.1.1.4.3 Weaknesses & competitive threats 362
13.1.2 ABBOTT LABORATORIES 363
13.1.2.1 Business overview 363
13.1.2.2 Products offered 364
13.1.2.3 Recent developments 366
13.1.2.3.1 Deals 366
13.1.2.4 MnM view 366
13.1.2.4.1 Key strengths 366
13.1.2.4.2 Strategic choices 366
13.1.2.4.3 Weaknesses & competitive threats 366
13.1.3 BOSTON SCIENTIFIC CORPORATION 367
13.1.3.1 Business overview 367
13.1.3.2 Products offered 368
13.1.3.3 Recent developments 370
13.1.3.3.1 Deals 370
13.1.3.4 MnM view 371
13.1.3.4.1 Key strengths 371
13.1.3.4.2 Strategic choices 371
13.1.3.4.3 Weaknesses & competitive threats 371
13.1.4 B. BRAUN SE 372
13.1.4.1 Business overview 372
13.1.4.2 Products offered 373
13.1.4.3 MnM view 374
13.1.4.3.1 Key strengths 374
13.1.4.3.2 Strategic choices 374
13.1.4.3.3 Weaknesses & competitive threats 374
13.1.5 TERUMO CORPORATION 375
13.1.5.1 Business overview 375
13.1.5.2 Products offered 376
13.1.5.3 Recent developments 378
13.1.5.3.1 Product approvals 378
13.1.5.4 MnM view 378
13.1.5.4.1 Key strengths 378
13.1.5.4.2 Strategic choices 378
13.1.5.4.3 Weaknesses & competitive threats 378
13.1.6 BIOTRONIK SE & CO. KG. 379
13.1.6.1 Business overview 379
13.1.6.2 Products offered 379
13.1.7 SHANGHAI MICROPORT MEDICAL (GROUP) CO., LTD. 380
13.1.7.1 Business overview 380
13.1.7.2 Products offered 382
13.1.7.3 Recent developments 384
13.1.7.3.1 Product launches & approvals 384
13.1.8 MERIL LIFE SCIENCES PVT. LTD. 386
13.1.8.1 Business overview 386
13.1.8.2 Products offered 386
13.1.9 SAHAJANAND MEDICAL TECHNOLOGIES LIMITED 388
13.1.9.1 Business overview 388
13.1.9.2 Products offered 388
13.1.10 BECTON, DICKINSON AND COMPANY 390
13.1.10.1 Business overview 390
13.1.10.2 Products offered 391
13.1.11 W. L. GORE & ASSOCIATES, INC. 393
13.1.11.1 Business overview 393
13.1.11.2 Products offered 393
13.1.11.3 Recent developments 394
13.1.11.3.1 Product launches & approvals 394
13.1.12 CORDIS CORPORATION (SUBSIDIARY OF HELLMAN & FRIEDMAN LLC) 395
13.1.12.1 Business overview 395
13.1.12.2 Products offered 395
13.1.12.3 Recent developments 396
13.1.12.3.1 Product approvals 396
13.1.12.3.2 Other developments 396
13.1.13 ARTIVION, INC. 397
13.1.13.1 Business overview 397
13.1.13.2 Products offered 398
13.1.13.3 Recent developments 399
13.1.13.3.1 Other developments 399
13.1.14 STRYKER CORPORATION 400
13.1.14.1 Business overview 400
13.1.14.2 Products offered 401
13.1.15 LIFETECH SCIENTIFIC CORPORATION 402
13.1.15.1 Business overview 402
13.1.15.2 Products offered 403
13.1.16 TRANSLUMINA 404
13.1.16.1 Business overview 404
13.1.16.2 Products offered 404
13.1.17 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. 406
13.1.17.1 Business overview 406
13.1.17.2 Products offered. 407
13.1.18 ENDOLOGIX LLC. 408
13.1.18.1 Business overview 408
13.1.18.2 Products offered 408
13.1.19 BIOSENSORS INTERNATIONAL GROUP, LTD. 409
13.1.19.1 Business overview 409
13.1.19.2 Products offered 409
13.1.19.3 Recent developments 410
13.1.19.3.1 Product approvals 410
13.2 OTHER PLAYERS 411
13.2.1 COOK MEDICAL 411
13.2.2 INSITU TECHNOLOGIES INC. 412
13.2.3 IVASCULAR 413
13.2.4 ORBUSNEICH MEDICAL GROUP HOLDINGS LIMITED 414
13.2.5 ALVIMEDICA 415
13.2.6 ELIXIR MEDICAL 416
14 APPENDIX 417
14.1 DISCUSSION GUIDE 417
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 423
14.3 CUSTOMIZATION OPTIONS 425
14.4 RELATED REPORTS 425
14.5 AUTHOR DETAILS 426
LIST OF TABLES
TABLE 1 CURRENCY CONVERSION RATES 40
TABLE 2 VASCULAR STENTS MARKET: STUDY ASSUMPTIONS 54
TABLE 3 VASCULAR STENTS MARKET: RISK ASSESSMENT ANALYSIS 55
TABLE 4 PORTER’S FIVE FORCES ANALYSIS 76
TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 80
TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 81
TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 81
TABLE 8 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 82
TABLE 9 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT
AGENCIES, AND OTHER ORGANIZATIONS 82
TABLE 10 LIST OF PATENTS IN VASCULAR STENTS MARKET, 2014−2024 85
TABLE 11 IMPORT DATA FOR VASCULAR STENTS, BY COUNTRY, 2018–2023 (USD MILLION) 86
TABLE 12 EXPORT DATA FOR VASCULAR STENTS, BY COUNTRY, 2018–2023 (USD MILLION) 86
TABLE 13 VASCULAR STENTS MARKET: AVERAGE SELLING PRICE 87
TABLE 14 REGIONAL AVERAGE PRICING ANALYSIS OF VASCULAR STENTS, 2023 87
TABLE 15 VASCULAR STENTS MARKET: KEY CONFERENCES & EVENTS, 2024–2025 88
TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VASCULAR STENTS 89
TABLE 17 KEY BUYING CRITERIA FOR VASCULAR STENTS, BY PRODUCT 90
TABLE 18 VASCULAR STENTS MARKET: UNMET NEEDS 90
TABLE 19 VASCULAR STENTS MARKET: END-USER EXPECTATIONS 91
TABLE 20 VASCULAR STENTS MARKET: IMPACT OF GENERATIVE AI 91
TABLE 21 VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 101
TABLE 22 VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION) 101
TABLE 23 DRUG-ELUTING STENTS OFFERED BY KEY PLAYERS 102
TABLE 24 DRUG-ELUTING STENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 103
TABLE 25 DRUG-ELUTING STENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 104
TABLE 26 BARE METAL STENTS OFFERED BY KEY PLAYERS 105
TABLE 27 BARE METAL STENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 106
TABLE 28 BARE METAL STENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 107
TABLE 29 COVERED STENTS OFFERED BY KEY PLAYERS 108
TABLE 30 COVERED STENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 109
TABLE 31 COVERED STENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 110
TABLE 32 BIOABSORBABLE STENTS OFFERED BY KEY PLAYERS 111
TABLE 33 BIOABSORBABLE STENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 111
TABLE 34 BIOABSORBABLE STENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 112
TABLE 35 VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 114
TABLE 36 VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION) 114
TABLE 37 CORONARY STENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 115
TABLE 38 CORONARY STENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 116
TABLE 39 PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 117
TABLE 40 PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 117
TABLE 41 PERIPHERAL STENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 118
TABLE 42 PERIPHERAL STENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 119
TABLE 43 CAROTID ARTERY STENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 120
TABLE 44 CAROTID ARTERY STENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 121
TABLE 45 FEMORAL ARTERY STENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 122
TABLE 46 FEMORAL ARTERY STENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 123
TABLE 47 RENAL ARTERY STENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 124
TABLE 48 RENAL ARTERY STENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 125
TABLE 49 ILIAC ARTERY STENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 126
TABLE 50 ILIAC ARTERY STENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 127
TABLE 51 OTHER PERIPHERAL STENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 128
TABLE 52 OTHER PERIPHERAL STENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 129
TABLE 53 EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 130
TABLE 54 EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 130
TABLE 55 ABDOMINAL AORTIC ANEURYSM STENT GRAFTS MARKET, BY COUNTRY,
2021–2023 (USD MILLION) 131
TABLE 56 ABDOMINAL AORTIC ANEURYSM STENT GRAFTS MARKET, BY COUNTRY,
2024–2029 (USD MILLION) 132
TABLE 57 THORACIC AORTIC ANEURYSM STENT GRAFTS MARKET, BY COUNTRY,
2021–2023 (USD MILLION) 133
TABLE 58 THORACIC AORTIC ANEURYSM STENT GRAFTS MARKET, BY COUNTRY,
2024–2029 (USD MILLION) 134
TABLE 59 VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021–2023 (USD MILLION) 136
TABLE 60 VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024–2029 (USD MILLION) 136
TABLE 61 BALLOON-EXPANDABLE STENTS OFFERED BY KEY PLAYERS 137
TABLE 62 BALLOON-EXPANDABLE STENTS MARKET, BY COUNTRY,
2021–2023 (USD MILLION) 138
TABLE 63 BALLOON-EXPANDABLE STENTS MARKET, BY COUNTRY,
2024–2029 (USD MILLION) 139
TABLE 64 SELF-EXPANDING STENTS PROVIDED BY KEY PLAYERS 140
TABLE 65 SELF-EXPANDING STENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 141
TABLE 66 SELF-EXPANDING STENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 142
TABLE 67 VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION) 144
TABLE 68 VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION) 144
TABLE 69 VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE,
2021–2023 (USD MILLION) 145
TABLE 70 VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE,
2024–2029 (USD MILLION) 145
TABLE 71 VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY COUNTRY,
2021–2023 (USD MILLION) 146
TABLE 72 VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY COUNTRY,
2024–2029 (USD MILLION) 147
TABLE 73 VASCULAR STENTS MARKET FOR COBALT CHROMIUM, BY COUNTRY,
2021–2023 (USD MILLION) 148
TABLE 74 VASCULAR STENTS MARKET FOR COBALT CHROMIUM, BY COUNTRY,
2024–2029 (USD MILLION) 149
TABLE 75 VASCULAR STENTS MARKET FOR PLATINUM CHROMIUM, BY COUNTRY,
2021–2023 (USD MILLION) 150
TABLE 76 VASCULAR STENTS MARKET FOR PLATINUM CHROMIUM, BY COUNTRY,
2024–2029 (USD MILLION) 151
TABLE 77 VASCULAR STENTS MARKET FOR NICKEL TITANIUM, BY COUNTRY,
2021–2023 (USD MILLION) 152
TABLE 78 VASCULAR STENTS MARKET FOR NICKEL TITANIUM, BY COUNTRY,
2024–2029 (USD MILLION) 153
TABLE 79 VASCULAR STENTS MARKET FOR STAINLESS STEEL, BY COUNTRY,
2021–2023 (USD MILLION) 154
TABLE 80 VASCULAR STENTS MARKET FOR STAINLESS STEEL, BY COUNTRY,
2024–2029 (USD MILLION) 155
TABLE 81 VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE,
2021–2023 (USD MILLION) 156
TABLE 82 VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE,
2024–2029 (USD MILLION) 156
TABLE 83 VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, COUNTRY,
2021–2023 (USD MILLION) 157
TABLE 84 VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY COUNTRY,
2024–2029 (USD MILLION) 158
TABLE 85 VASCULAR STENTS MARKET FOR BIODEGRADABLE POLYMERS, BY COUNTRY, 2021–2023 (USD MILLION) 159
TABLE 86 VASCULAR STENTS MARKET FOR BIODEGRADABLE POLYMERS, BY COUNTRY, 2024–2029 (USD MILLION) 160
TABLE 87 VASCULAR STENTS MARKET FOR NON-BIODEGRADABLE POLYMERS, BY COUNTRY, 2021–2023 (USD MILLION) 161
TABLE 88 VASCULAR STENTS MARKET FOR NON-BIODEGRADABLE POLYMERS, BY COUNTRY, 2024–2029 (USD MILLION) 162
TABLE 89 VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION) 164
TABLE 90 VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION) 164
TABLE 91 VASCULAR STENTS MARKET FOR HOSPITALS, BY COUNTRY,
2021–2023 (USD MILLION) 165
TABLE 92 VASCULAR STENTS MARKET FOR HOSPITALS, BY COUNTRY,
2024–2029 (USD MILLION) 166
TABLE 93 VASCULAR STENTS MARKET FOR CARDIAC CENTERS, BY COUNTRY,
2021–2023 (USD MILLION) 167
TABLE 94 VASCULAR STENTS MARKET FOR CARDIAC CENTERS, BY COUNTRY,
2024–2029 (USD MILLION) 168
TABLE 95 VASCULAR STENTS MARKET, BY REGION, 2021–2023 (USD MILLION) 170
TABLE 96 VASCULAR STENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 170
TABLE 97 VASCULAR STENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 171
TABLE 98 VASCULAR STENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 172
TABLE 99 NORTH AMERICA: VASCULAR STENTS MARKET, BY COUNTRY,
2021–2023 (USD MILLION) 174
TABLE 100 NORTH AMERICA: VASCULAR STENTS MARKET, BY COUNTRY,
2024–2029 (USD MILLION) 174
TABLE 101 NORTH AMERICA: VASCULAR STENTS MARKET, BY PRODUCT,
2021–2023 (USD MILLION) 174
TABLE 102 NORTH AMERICA: VASCULAR STENTS MARKET, BY PRODUCT,
2024–2029 (USD MILLION) 175
TABLE 103 NORTH AMERICA: PERIPHERAL STENTS MARKET, BY TYPE,
2021–2023 (USD MILLION) 175
TABLE 104 NORTH AMERICA: PERIPHERAL STENTS MARKET, BY TYPE,
2024–2029 (USD MILLION) 175
TABLE 105 NORTH AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE,
2021–2023 (USD MILLION) 176
TABLE 106 NORTH AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE,
2024–2029 (USD MILLION) 176
TABLE 107 NORTH AMERICA: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2021–2023 (USD MILLION) 176
TABLE 108 NORTH AMERICA: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2024–2029 (USD MILLION) 177
TABLE 109 NORTH AMERICA: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2021–2029 (THOUSAND UNITS) 177
TABLE 110 NORTH AMERICA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2021–2023 (USD MILLION) 177
TABLE 111 NORTH AMERICA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2024–2029 (USD MILLION) 178
TABLE 112 NORTH AMERICA: VASCULAR STENTS MARKET, BY MATERIAL,
2021–2023 (USD MILLION) 178
TABLE 113 NORTH AMERICA: VASCULAR STENTS MARKET, BY MATERIAL,
2024–2029 (USD MILLION) 178
TABLE 114 NORTH AMERICA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS,
BY TYPE, 2021–2023 (USD MILLION) 179
TABLE 115 NORTH AMERICA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS,
BY TYPE, 2024–2029 (USD MILLION) 179
TABLE 116 NORTH AMERICA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS,
BY TYPE, 2021–2023 (USD MILLION) 179
TABLE 117 NORTH AMERICA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS,
BY TYPE, 2024–2029 (USD MILLION) 180
TABLE 118 NORTH AMERICA: VASCULAR STENTS MARKET, BY END USER,
2021–2023 (USD MILLION) 180
TABLE 119 NORTH AMERICA: VASCULAR STENTS MARKET, BY END USER,
2024–2029 (USD MILLION) 180
TABLE 120 US: KEY MACROINDICATORS 181
TABLE 121 US: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 182
TABLE 122 US: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION) 182
TABLE 123 US: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 182
TABLE 124 US: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 183
TABLE 125 US: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 183
TABLE 126 US: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 183
TABLE 127 US: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 184
TABLE 128 US: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION) 184
TABLE 129 US: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2021–2023 (USD MILLION) 184
TABLE 130 US: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2024–2029 (USD MILLION) 185
TABLE 131 US: VASCULAR STENTS MARKET, BY MATERIAL,
2021–2023 (USD MILLION) 185
TABLE 132 US: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION) 185
TABLE 133 US: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE,
2021–2023 (USD MILLION) 186
TABLE 134 US: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE,
2024–2029 (USD MILLION) 186
TABLE 135 US: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE,
2021–2023 (USD MILLION) 186
TABLE 136 US: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE,
2024–2029 (USD MILLION) 187
TABLE 137 US: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION) 187
TABLE 138 US: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION) 187
TABLE 139 CANADA: KEY MACROINDICATORS 188
TABLE 140 CANADA: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 188
TABLE 141 CANADA: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION) 189
TABLE 142 CANADA: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 189
TABLE 143 CANADA: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 189
TABLE 144 CANADA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 190
TABLE 145 CANADA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 190
TABLE 146 CANADA: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2021–2023 (USD MILLION) 190
TABLE 147 CANADA: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2024–2029 (USD MILLION) 191
TABLE 148 CANADA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2021–2023 (USD MILLION) 191
TABLE 149 CANADA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2024–2029 (USD MILLION) 191
TABLE 150 CANADA: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION) 192
TABLE 151 CANADA: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION) 192
TABLE 152 CANADA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE,
2021–2023 (USD MILLION) 192
TABLE 153 CANADA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE,
2024–2029 (USD MILLION) 193
TABLE 154 CANADA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION) 193
TABLE 155 CANADA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION) 193
TABLE 156 CANADA: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION) 194
TABLE 157 CANADA: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION) 194
TABLE 158 EUROPE: VASCULAR STENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 195
TABLE 159 EUROPE: VASCULAR STENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 195
TABLE 160 EUROPE: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 196
TABLE 161 EUROPE: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION) 196
TABLE 162 EUROPE: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 196
TABLE 163 PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 197
TABLE 164 EUROPE: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 197
TABLE 165 EUROPE: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 197
TABLE 166 EUROPE: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2021–2023 (USD MILLION) 198
TABLE 167 EUROPE: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2024–2029 (USD MILLION) 198
TABLE 168 EUROPE: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2021–2029 (THOUSAND UNITS) 198
TABLE 169 EUROPE: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2021–2023 (USD MILLION) 199
TABLE 170 EUROPE: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2024–2029 (USD MILLION) 199
TABLE 171 EUROPE: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION) 199
TABLE 172 EUROPE: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION) 200
TABLE 173 EUROPE: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE,
2021–2023 (USD MILLION) 200
TABLE 174 EUROPE: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE,
2024–2029 (USD MILLION) 200
TABLE 175 EUROPE: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION) 201
TABLE 176 EUROPE: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION) 201
TABLE 177 EUROPE: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION) 201
TABLE 178 EUROPE: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION) 202
TABLE 179 GERMANY: KEY MACROINDICATORS 202
TABLE 180 GERMANY: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 203
TABLE 181 GERMANY: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION) 203
TABLE 182 GERMANY: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 203
TABLE 183 GERMANY: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 204
TABLE 184 GERMANY: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 204
TABLE 185 GERMANY: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 204
TABLE 186 GERMANY: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2021–2023 (USD MILLION) 205
TABLE 187 GERMANY: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2024–2029 (USD MILLION) 205
TABLE 188 GERMANY: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2021–2023 (USD MILLION) 205
TABLE 189 GERMANY: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2024–2029 (USD MILLION) 206
TABLE 190 GERMANY: VASCULAR STENTS MARKET, BY MATERIAL,
2021–2023 (USD MILLION) 206
TABLE 191 GERMANY: VASCULAR STENTS MARKET, BY MATERIAL,
2024–2029 (USD MILLION) 206
TABLE 192 GERMANY: VASCULAR STENTS MARKET FOR METALLIC MATERIALS,
BY TYPE, 2021–2023 (USD MILLION) 207
TABLE 193 GERMANY: VASCULAR STENTS MARKET FOR METALLIC MATERIALS,
BY TYPE, 2024–2029 (USD MILLION) 207
TABLE 194 GERMANY: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS,
BY TYPE, 2021–2023 (USD MILLION) 207
TABLE 195 GERMANY: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS,
BY TYPE, 2024–2029 (USD MILLION) 208
TABLE 196 GERMANY: VASCULAR STENTS MARKET, BY END USER,
2021–2023 (USD MILLION) 208
TABLE 197 GERMANY: VASCULAR STENTS MARKET, BY END USER,
2024–2029 (USD MILLION) 208
TABLE 198 UK: KEY MACROINDICATORS 209
TABLE 199 UK: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 209
TABLE 200 UK: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION) 210
TABLE 201 UK: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 210
TABLE 202 UK: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 210
TABLE 203 UK: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 211
TABLE 204 UK: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 211
TABLE 205 UK: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 211
TABLE 206 UK: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION) 212
TABLE 207 UK: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2021–2023 (USD MILLION) 212
TABLE 208 UK: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2024–2029 (USD MILLION) 212
TABLE 209 UK: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION) 213
TABLE 210 UK: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION) 213
TABLE 211 UK: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE,
2021–2023 (USD MILLION) 213
TABLE 212 UK: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE,
2024–2029 (USD MILLION) 214
TABLE 213 UK: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE,
2021–2023 (USD MILLION) 214
TABLE 214 UK: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE,
2024–2029 (USD MILLION) 214
TABLE 215 UK: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION) 215
TABLE 216 UK: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION) 215
TABLE 217 FRANCE: KEY MACROINDICATORS 216
TABLE 218 FRANCE: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 216
TABLE 219 FRANCE: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION) 216
TABLE 220 FRANCE: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 217
TABLE 221 FRANCE: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 217
TABLE 222 FRANCE: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 217
TABLE 223 FRANCE: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 218
TABLE 224 FRANCE: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2021–2023 (USD MILLION) 218
TABLE 225 FRANCE: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2024–2029 (USD MILLION) 218
TABLE 226 FRANCE: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2021–2023 (USD MILLION) 219
TABLE 227 FRANCE: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2024–2029 (USD MILLION) 219
TABLE 228 FRANCE: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION) 219
TABLE 229 FRANCE: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION) 220
TABLE 230 FRANCE: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE,
2021–2023 (USD MILLION) 220
TABLE 231 FRANCE: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE,
2024–2029 (USD MILLION) 220
TABLE 232 FRANCE: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION) 221
TABLE 233 FRANCE: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION) 221
TABLE 234 FRANCE: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION) 221
TABLE 235 FRANCE: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION) 222
TABLE 236 ITALY: KEY MACROINDICATORS 222
TABLE 237 ITALY: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 223
TABLE 238 ITALY: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION) 223
TABLE 239 ITALY: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 223
TABLE 240 ITALY: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 224
TABLE 241 ITALY: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 224
TABLE 242 ITALY: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 224
TABLE 243 ITALY: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 225
TABLE 244 ITALY: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION) 225
TABLE 245 ITALY: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2021–2023 (USD MILLION) 225
TABLE 246 ITALY: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2024–2029 (USD MILLION) 226
TABLE 247 ITALY: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION) 226
TABLE 248 ITALY: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION) 226
TABLE 249 ITALY: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE,
2021–2023 (USD MILLION) 227
TABLE 250 ITALY: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE,
2024–2029 (USD MILLION) 227
TABLE 251 ITALY: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE,
2021–2023 (USD MILLION) 227
TABLE 252 ITALY: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE,
2024–2029 (USD MILLION) 228
TABLE 253 ITALY: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION) 228
TABLE 254 ITALY: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION) 228
TABLE 255 SPAIN: KEY MACROINDICATORS 229
TABLE 256 SPAIN: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 229
TABLE 257 SPAIN: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION) 229
TABLE 258 SPAIN: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 230
TABLE 259 SPAIN: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 230
TABLE 260 SPAIN: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 230
TABLE 261 SPAIN: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 231
TABLE 262 SPAIN: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 231
TABLE 263 SPAIN: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION) 231
TABLE 264 SPAIN: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2021–2023 (USD MILLION) 232
TABLE 265 SPAIN: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2024–2029 (USD MILLION) 232
TABLE 266 SPAIN: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION) 232
TABLE 267 SPAIN: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION) 232
TABLE 268 SPAIN: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE,
2021–2023 (USD MILLION) 233
TABLE 269 SPAIN: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE,
2024–2029 (USD MILLION) 233
TABLE 270 SPAIN: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE,
2021–2023 (USD MILLION) 233
TABLE 271 SPAIN: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE,
2024–2029 (USD MILLION) 234
TABLE 272 SPAIN: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION) 234
TABLE 273 SPAIN: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION) 234
TABLE 274 REST OF EUROPE: VASCULAR STENTS MARKET, BY PRODUCT,
2021–2023 (USD MILLION) 235
TABLE 275 REST OF EUROPE: VASCULAR STENTS MARKET, BY PRODUCT,
2024–2029 (USD MILLION) 235
TABLE 276 REST OF EUROPE: PERIPHERAL STENTS MARKET, BY TYPE,
2021–2023 (USD MILLION) 235
TABLE 277 REST OF EUROPE: PERIPHERAL STENTS MARKET, BY TYPE,
2024–2029 (USD MILLION) 236
TABLE 278 REST OF EUROPE: EVAR STENT GRAFTS MARKET, BY TYPE,
2021–2023 (USD MILLION) 236
TABLE 279 REST OF EUROPE: EVAR STENT GRAFTS MARKET, BY TYPE,
2024–2029 (USD MILLION) 236
TABLE 280 REST OF EUROPE: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2021–2023 (USD MILLION) 237
TABLE 281 REST OF EUROPE: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2024–2029 (USD MILLION) 237
TABLE 282 REST OF EUROPE: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2021–2023 (USD MILLION) 237
TABLE 283 REST OF EUROPE: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2024–2029 (USD MILLION) 238
TABLE 284 REST OF EUROPE: VASCULAR STENTS MARKET, BY MATERIAL,
2021–2023 (USD MILLION) 238
TABLE 285 REST OF EUROPE: VASCULAR STENTS MARKET, BY MATERIAL,
2024–2029 (USD MILLION) 238
TABLE 286 REST OF EUROPE: VASCULAR STENTS MARKET FOR METALLIC MATERIALS,
BY TYPE, 2021–2023 (USD MILLION) 239
TABLE 287 REST OF EUROPE: VASCULAR STENTS MARKET FOR METALLIC MATERIALS,
BY TYPE, 2024–2029 (USD MILLION) 239
TABLE 288 REST OF EUROPE: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS,
BY TYPE, 2021–2023 (USD MILLION) 239
TABLE 289 REST OF EUROPE: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS,
BY TYPE, 2024–2029 (USD MILLION) 240
TABLE 290 REST OF EUROPE: VASCULAR STENTS MARKET, BY END USER,
2021–2023 (USD MILLION) 240
TABLE 291 REST OF EUROPE: VASCULAR STENTS MARKET, BY END USER,
2024–2029 (USD MILLION) 240
TABLE 292 ASIA PACIFIC: VASCULAR STENTS MARKET, BY COUNTRY,
2021–2023 (USD MILLION) 243
TABLE 293 ASIA PACIFIC: VASCULAR STENTS MARKET, BY COUNTRY,
2024–2029 (USD MILLION) 243
TABLE 294 ASIA PACIFIC: VASCULAR STENTS MARKET, BY PRODUCT,
2021–2023 (USD MILLION) 243
TABLE 295 ASIA PACIFIC: VASCULAR STENTS MARKET, BY PRODUCT,
2024–2029 (USD MILLION) 244
TABLE 296 ASIA PACIFIC: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 244
TABLE 297 ASIA PACIFIC: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 244
TABLE 298 ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 245
TABLE 299 ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 245
TABLE 300 ASIA PACIFIC: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2021–2023 (USD MILLION) 245
TABLE 301 ASIA PACIFIC: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2024–2029 (USD MILLION) 246
TABLE 302 ASIA PACIFIC: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2021–2029 (THOUSAND UNITS) 246
TABLE 303 ASIA PACIFIC: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2021–2023 (USD MILLION) 246
TABLE 304 ASIA PACIFIC: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2024–2029 (USD MILLION) 247
TABLE 305 ASIA PACIFIC: VASCULAR STENTS MARKET, BY MATERIAL,
2021–2023 (USD MILLION) 247
TABLE 306 ASIA PACIFIC: VASCULAR STENTS MARKET, BY MATERIAL,
2024–2029 (USD MILLION) 247
TABLE 307 ASIA PACIFIC: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION) 248
TABLE 308 ASIA PACIFIC: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION) 248
TABLE 309 ASIA PACIFIC: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION) 248
TABLE 310 ASIA PACIFIC: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION) 249
TABLE 311 ASIA PACIFIC: VASCULAR STENTS MARKET, BY END USER,
2021–2023 (USD MILLION) 249
TABLE 312 ASIA PACIFIC: VASCULAR STENTS MARKET, BY END USER,
2024–2029 (USD MILLION) 249
TABLE 313 CHINA: KEY MACROINDICATORS 250
TABLE 314 CHINA: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 250
TABLE 315 CHINA: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION) 251
TABLE 316 CHINA: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 251
TABLE 317 CHINA: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 252
TABLE 318 CHINA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 252
TABLE 319 CHINA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 252
TABLE 320 CHINA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 253
TABLE 321 CHINA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION) 253
TABLE 322 CHINA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2021–2023 (USD MILLION) 253
TABLE 323 CHINA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2024–2029 (USD MILLION) 254
TABLE 324 CHINA: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION) 254
TABLE 325 CHINA: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION) 254
TABLE 326 CHINA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE,
2021–2023 (USD MILLION) 255
TABLE 327 CHINA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE,
2024–2029 (USD MILLION) 255
TABLE 328 CHINA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE,
2021–2023 (USD MILLION) 255
TABLE 329 CHINA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE,
2024–2029 (USD MILLION) 256
TABLE 330 CHINA: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION) 256
TABLE 331 CHINA: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION) 256
TABLE 332 JAPAN: KEY MACROINDICATORS 257
TABLE 333 JAPAN: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 257
TABLE 334 JAPAN: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION) 258
TABLE 335 JAPAN: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 258
TABLE 336 JAPAN: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 258
TABLE 337 JAPAN: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 259
TABLE 338 JAPAN: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 259
TABLE 339 JAPAN: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 259
TABLE 340 JAPAN: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION) 260
TABLE 341 JAPAN: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2021–2023 (USD MILLION) 260
TABLE 342 JAPAN: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2024–2029 (USD MILLION) 260
TABLE 343 JAPAN: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION) 261
TABLE 344 JAPAN: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION) 261
TABLE 345 JAPAN: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE,
2021–2023 (USD MILLION) 261
TABLE 346 JAPAN: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE,
2024–2029 (USD MILLION) 262
TABLE 347 JAPAN: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE,
2021–2023 (USD MILLION) 262
TABLE 348 JAPAN: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE,
2024–2029 (USD MILLION) 262
TABLE 349 JAPAN: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION) 263
TABLE 350 JAPAN: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION) 263
TABLE 351 INDIA: KEY MACROINDICATORS 264
TABLE 352 INDIA: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 264
TABLE 353 INDIA: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION) 264
TABLE 354 INDIA: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 265
TABLE 355 INDIA: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 265
TABLE 356 INDIA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 265
TABLE 357 INDIA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 266
TABLE 358 INDIA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 266
TABLE 359 INDIA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION) 266
TABLE 360 INDIA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2021–2023 (USD MILLION) 267
TABLE 361 INDIA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2024–2029 (USD MILLION) 267
TABLE 362 INDIA: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION) 267
TABLE 363 INDIA: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION) 268
TABLE 364 INDIA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE,
2021–2023 (USD MILLION) 268
TABLE 365 INDIA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE,
2024–2029 (USD MILLION) 268
TABLE 366 INDIA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE,
2021–2023 (USD MILLION) 269
TABLE 367 INDIA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE,
2024–2029 (USD MILLION) 269
TABLE 368 INDIA: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION) 269
TABLE 369 INDIA: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION) 270
TABLE 370 AUSTRALIA: KEY MACROINDICATORS 270
TABLE 371 AUSTRALIA: VASCULAR STENTS MARKET, BY PRODUCT,
2021–2023 (USD MILLION) 271
TABLE 372 AUSTRALIA: VASCULAR STENTS MARKET, BY PRODUCT,
2024–2029 (USD MILLION) 271
TABLE 373 AUSTRALIA: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 271
TABLE 374 AUSTRALIA: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 272
TABLE 375 AUSTRALIA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 272
TABLE 376 AUSTRALIA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 272
TABLE 377 AUSTRALIA: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2021–2023 (USD MILLION) 273
TABLE 378 AUSTRALIA: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2024–2029 (USD MILLION) 273
TABLE 379 AUSTRALIA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2021–2023 (USD MILLION) 273
TABLE 380 AUSTRALIA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2024–2029 (USD MILLION) 274
TABLE 381 AUSTRALIA: VASCULAR STENTS MARKET, BY MATERIAL,
2021–2023 (USD MILLION) 274
TABLE 382 AUSTRALIA: VASCULAR STENTS MARKET, BY MATERIAL,
2024–2029 (USD MILLION) 274
TABLE 383 AUSTRALIA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION) 275
TABLE 384 AUSTRALIA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION) 275
TABLE 385 AUSTRALIA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION) 275
TABLE 386 AUSTRALIA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION) 276
TABLE 387 AUSTRALIA: VASCULAR STENTS MARKET, BY END USER,
2021–2023 (USD MILLION) 276
TABLE 388 AUSTRALIA: VASCULAR STENTS MARKET, BY END USER,
2024–2029 (USD MILLION) 276
TABLE 389 SOUTH KOREA: KEY MACROINDICATORS 277
TABLE 390 SOUTH KOREA: VASCULAR STENTS MARKET, BY PRODUCT,
2021–2023 (USD MILLION) 277
TABLE 391 SOUTH KOREA: VASCULAR STENTS MARKET, BY PRODUCT,
2024–2029 (USD MILLION) 278
TABLE 392 SOUTH KOREA: PERIPHERAL STENTS MARKET, BY TYPE,
2021–2023 (USD MILLION) 278
TABLE 393 SOUTH KOREA: PERIPHERAL STENTS MARKET, BY TYPE,
2024–2029 (USD MILLION) 278
TABLE 394 SOUTH KOREA: EVAR STENT GRAFTS MARKET, BY TYPE,
2021–2023 (USD MILLION) 279
TABLE 395 SOUTH KOREA: EVAR STENT GRAFTS MARKET, BY TYPE,
2024–2029 (USD MILLION) 279
TABLE 396 SOUTH KOREA: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2021–2023 (USD MILLION) 279
TABLE 397 SOUTH KOREA: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2024–2029 (USD MILLION) 280
TABLE 398 SOUTH KOREA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2021–2023 (USD MILLION) 280
TABLE 399 SOUTH KOREA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2024–2029 (USD MILLION) 280
TABLE 400 SOUTH KOREA: VASCULAR STENTS MARKET, BY MATERIAL,
2021–2023 (USD MILLION) 281
TABLE 401 SOUTH KOREA: VASCULAR STENTS MARKET, BY MATERIAL,
2024–2029 (USD MILLION) 281
TABLE 402 SOUTH KOREA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS,
BY TYPE, 2021–2023 (USD MILLION) 281
TABLE 403 SOUTH KOREA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS,
BY TYPE, 2024–2029 (USD MILLION) 282
TABLE 404 SOUTH KOREA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS,
BY TYPE, 2021–2023 (USD MILLION) 282
TABLE 405 SOUTH KOREA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS,
BY TYPE, 2024–2029 (USD MILLION) 282
TABLE 406 SOUTH KOREA: VASCULAR STENTS MARKET, BY END USER,
2021–2023 (USD MILLION) 283
TABLE 407 SOUTH KOREA: VASCULAR STENTS MARKET, BY END USER,
2024–2029 (USD MILLION) 283
TABLE 408 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET, BY PRODUCT,
2021–2023 (USD MILLION) 284
TABLE 409 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET, BY PRODUCT,
2024–2029 (USD MILLION) 284
TABLE 410 REST OF ASIA PACIFIC: PERIPHERAL STENTS MARKET, BY TYPE,
2021–2023 (USD MILLION) 284
TABLE 411 REST OF ASIA PACIFIC: PERIPHERAL STENTS MARKET, BY TYPE,
2024–2029 (USD MILLION) 285
TABLE 412 REST OF ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE,
2021–2023 (USD MILLION) 285
TABLE 413 REST OF ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE,
2024–2029 (USD MILLION) 285
TABLE 414 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2021–2023 (USD MILLION) 286
TABLE 415 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2024–2029 (USD MILLION) 286
TABLE 416 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021–2023 (USD MILLION) 286
TABLE 417 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024–2029 (USD MILLION) 287
TABLE 418 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET, BY MATERIAL,
2021–2023 (USD MILLION) 287
TABLE 419 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET, BY MATERIAL,
2024–2029 (USD MILLION) 287
TABLE 420 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET FOR METALLIC MATERIALS,
BY TYPE, 2021–2023 (USD MILLION) 288
TABLE 421 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET FOR METALLIC MATERIALS,
BY TYPE, 2024–2029 (USD MILLION) 288
TABLE 422 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION) 288
TABLE 423 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION) 289
TABLE 424 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET, BY END USER,
2021–2023 (USD MILLION) 289
TABLE 425 REST OF ASIA PACIFIC: VASCULAR STENTS MARKET, BY END USER,
2024–2029 (USD MILLION) 289
TABLE 426 LATIN AMERICA: VASCULAR STENTS MARKET, BY COUNTRY,
2021–2023 (USD MILLION) 290
TABLE 427 LATIN AMERICA: VASCULAR STENTS MARKET, BY COUNTRY,
2024–2029 (USD MILLION) 291
TABLE 428 LATIN AMERICA: VASCULAR STENTS MARKET, BY PRODUCT,
2021–2023 (USD MILLION) 291
TABLE 429 LATIN AMERICA: VASCULAR STENTS MARKET, BY PRODUCT,
2024–2029 (USD MILLION) 291
TABLE 430 LATIN AMERICA: PERIPHERAL STENTS MARKET, BY TYPE,
2021–2023 (USD MILLION) 292
TABLE 431 LATIN AMERICA: PERIPHERAL STENTS MARKET, BY TYPE,
2024–2029 (USD MILLION) 292
TABLE 432 LATIN AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE,
2021–2023 (USD MILLION) 292
TABLE 433 LATIN AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE,
2024–2029 (USD MILLION) 293
TABLE 434 LATIN AMERICA: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2021–2023 (USD MILLION) 293
TABLE 435 LATIN AMERICA: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2024–2029 (USD MILLION) 293
TABLE 436 LATIN AMERICA: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2021–2029 (THOUSAND UNITS) 294
TABLE 437 LATIN AMERICA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2021–2023 (USD MILLION) 294
TABLE 438 LATIN AMERICA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2024–2029 (USD MILLION) 294
TABLE 439 LATIN AMERICA: VASCULAR STENTS MARKET, BY MATERIAL,
2021–2023 (USD MILLION) 295
TABLE 440 LATIN AMERICA: VASCULAR STENTS MARKET, BY MATERIAL,
2024–2029 (USD MILLION) 295
TABLE 441 LATIN AMERICA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS,
BY TYPE, 2021–2023 (USD MILLION) 295
TABLE 442 LATIN AMERICA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS,
BY TYPE, 2024–2029 (USD MILLION) 296
TABLE 443 LATIN AMERICA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS,
BY TYPE, 2021–2023 (USD MILLION) 296
TABLE 444 LATIN AMERICA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS,
BY TYPE, 2024–2029 (USD MILLION) 296
TABLE 445 LATIN AMERICA: VASCULAR STENTS MARKET, BY END USER,
2021–2023 (USD MILLION) 297
TABLE 446 LATIN AMERICA: VASCULAR STENTS MARKET, BY END USER,
2024–2029 (USD MILLION) 297
TABLE 447 BRAZIL: KEY MACROINDICATORS 298
TABLE 448 BRAZIL: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 298
TABLE 449 BRAZIL: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION) 298
TABLE 450 BRAZIL: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 299
TABLE 451 BRAZIL: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 299
TABLE 452 BRAZIL: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 299
TABLE 453 BRAZIL: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 300
TABLE 454 BRAZIL: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2021–2023 (USD MILLION) 300
TABLE 455 BRAZIL: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2024–2029 (USD MILLION) 300
TABLE 456 BRAZIL: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2021–2023 (USD MILLION) 301
TABLE 457 BRAZIL: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2024–2029 (USD MILLION) 301
TABLE 458 BRAZIL: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION) 301
TABLE 459 BRAZIL: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION) 302
TABLE 460 BRAZIL: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE,
2021–2023 (USD MILLION) 302
TABLE 461 BRAZIL: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE,
2024–2029 (USD MILLION) 302
TABLE 462 BRAZIL: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS,
BY TYPE, 2021–2023 (USD MILLION) 303
TABLE 463 BRAZIL: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS,
BY TYPE, 2024–2029 (USD MILLION) 303
TABLE 464 BRAZIL: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION) 303
TABLE 465 BRAZIL: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION) 304
TABLE 466 MEXICO: KEY MACROINDICATORS 304
TABLE 467 MEXICO: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 305
TABLE 468 MEXICO: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION) 305
TABLE 469 MEXICO: PERIPHERAL STENTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 305
TABLE 470 MEXICO: PERIPHERAL STENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 306
TABLE 471 MEXICO: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 306
TABLE 472 MEXICO: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 306
TABLE 473 MEXICO: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2021–2023 (USD MILLION) 307
TABLE 474 MEXICO: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2024–2029 (USD MILLION) 307
TABLE 475 MEXICO: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2021–2023 (USD MILLION) 307
TABLE 476 MEXICO: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2024–2029 (USD MILLION) 308
TABLE 477 MEXICO: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION) 308
TABLE 478 MEXICO: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION) 308
TABLE 479 MEXICO: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE,
2021–2023 (USD MILLION) 309
TABLE 480 MEXICO: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE,
2024–2029 (USD MILLION) 309
TABLE 481 MEXICO: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION) 309
TABLE 482 MEXICO: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION) 310
TABLE 483 MEXICO: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION) 310
TABLE 484 MEXICO: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION) 310
TABLE 485 REST OF LATIN AMERICA: VASCULAR STENTS MARKET, BY PRODUCT,
2021–2023 (USD MILLION) 311
TABLE 486 REST OF LATIN AMERICA: VASCULAR STENTS MARKET, BY PRODUCT,
2024–2029 (USD MILLION) 311
TABLE 487 REST OF LATIN AMERICA: PERIPHERAL STENTS MARKET, BY TYPE,
2021–2023 (USD MILLION) 312
TABLE 488 REST OF LATIN AMERICA: PERIPHERAL STENTS MARKET, BY TYPE,
2024–2029 (USD MILLION) 312
TABLE 489 REST OF LATIN AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE,
2021–2023 (USD MILLION) 312
TABLE 490 REST OF LATIN AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE,
2024–2029 (USD MILLION) 313
TABLE 491 REST OF LATIN AMERICA: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2021–2023 (USD MILLION) 313
TABLE 492 REST OF LATIN AMERICA: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2024–2029 (USD MILLION) 313
TABLE 493 REST OF LATIN AMERICA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021–2023 (USD MILLION) 314
TABLE 494 REST OF LATIN AMERICA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024–2029 (USD MILLION) 314
TABLE 495 REST OF LATIN AMERICA: VASCULAR STENTS MARKET, BY MATERIAL,
2021–2023 (USD MILLION) 314
TABLE 496 REST OF LATIN AMERICA: VASCULAR STENTS MARKET, BY MATERIAL,
2024–2029 (USD MILLION) 315
TABLE 497 REST OF LATIN AMERICA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION) 315
TABLE 498 REST OF LATIN AMERICA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION) 315
TABLE 499 REST OF LATIN AMERICA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION) 316
TABLE 500 REST OF LATIN AMERICA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION) 316
TABLE 501 REST OF LATIN AMERICA: VASCULAR STENTS MARKET, BY END USER,
2021–2023 (USD MILLION) 316
TABLE 502 REST OF LATIN AMERICA: VASCULAR STENTS MARKET, BY END USER,
2024–2029 (USD MILLION) 317
TABLE 503 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY REGION,
2021–2023 (USD MILLION) 317
TABLE 504 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY REGION,
2024–2029 (USD MILLION) 318
TABLE 505 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY PRODUCT,
2021–2023 (USD MILLION) 318
TABLE 506 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY PRODUCT,
2024–2029 (USD MILLION) 318
TABLE 507 MIDDLE EAST & AFRICA: PERIPHERAL STENTS MARKET, BY TYPE,
2021–2023 (USD MILLION) 319
TABLE 508 MIDDLE EAST & AFRICA: PERIPHERAL STENTS MARKET, BY TYPE,
2024–2029 (USD MILLION) 319
TABLE 509 MIDDLE EAST & AFRICA: EVAR STENT GRAFTS MARKET, BY TYPE,
2021–2023 (USD MILLION) 319
TABLE 510 MIDDLE EAST & AFRICA: EVAR STENT GRAFTS MARKET, BY TYPE,
2024–2029 (USD MILLION) 320
TABLE 511 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2021–2023 (USD MILLION) 320
TABLE 512 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2024–2029 (USD MILLION) 320
TABLE 513 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2021–2029 (THOUSAND UNITS) 321
TABLE 514 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021–2023 (USD MILLION) 321
TABLE 515 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024–2029 (USD MILLION) 321
TABLE 516 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY MATERIAL,
2021–2023 (USD MILLION) 322
TABLE 517 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY MATERIAL,
2024–2029 (USD MILLION) 322
TABLE 518 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION) 322
TABLE 519 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION) 323
TABLE 520 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION) 323
TABLE 521 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION) 323
TABLE 522 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY END USER,
2021–2023 (USD MILLION) 324
TABLE 523 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY END USER,
2024–2029 (USD MILLION) 324
TABLE 524 GCC COUNTRIES: VASCULAR STENTS MARKET, BY PRODUCT,
2021–2023 (USD MILLION) 325
TABLE 525 GCC COUNTRIES: VASCULAR STENTS MARKET, BY PRODUCT,
2024–2029 (USD MILLION) 325
TABLE 526 GCC COUNTRIES: PERIPHERAL STENTS MARKET, BY TYPE,
2021–2023 (USD MILLION) 325
TABLE 527 GCC COUNTRIES: PERIPHERAL STENTS MARKET, BY TYPE,
2024–2029 (USD MILLION) 326
TABLE 528 GCC COUNTRIES: EVAR STENT GRAFTS MARKET, BY TYPE,
2021–2023 (USD MILLION) 326
TABLE 529 GCC COUNTRIES: EVAR STENT GRAFTS MARKET, BY TYPE,
2024–2029 (USD MILLION) 326
TABLE 530 GCC COUNTRIES: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2021–2023 (USD MILLION) 327
TABLE 531 GCC COUNTRIES: VASCULAR STENTS MARKET, BY TECHNOLOGY,
2024–2029 (USD MILLION) 327
TABLE 532 GCC COUNTRIES: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2021–2023 (USD MILLION) 327
TABLE 533 GCC COUNTRIES: VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2024–2029 (USD MILLION) 328
TABLE 534 GCC COUNTRIES: VASCULAR STENTS MARKET, BY MATERIAL,
2021–2023 (USD MILLION) 328
TABLE 535 GCC COUNTRIES: VASCULAR STENTS MARKET, BY MATERIAL,
2024–2029 (USD MILLION) 328
TABLE 536 GCC COUNTRIES: VASCULAR STENTS MARKET FOR METALLIC MATERIALS,
BY TYPE, 2021–2023 (USD MILLION) 329
TABLE 537 GCC COUNTRIES: VASCULAR STENTS MARKET FOR METALLIC MATERIALS,
BY TYPE, 2024–2029 (USD MILLION) 329
TABLE 538 GCC COUNTRIES: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS,
BY TYPE, 2021–2023 (USD MILLION) 329
TABLE 539 GCC COUNTRIES: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS,
BY TYPE, 2024–2029 (USD MILLION) 330
TABLE 540 GCC COUNTRIES: VASCULAR STENTS MARKET, BY END USER,
2021–2023 (USD MILLION) 330
TABLE 541 GCC COUNTRIES: VASCULAR STENTS MARKET, BY END USER,
2024–2029 (USD MILLION) 330
TABLE 542 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 331
TABLE 543 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY PRODUCT, 2024–2029 (USD MILLION) 331
TABLE 544 REST OF MIDDLE EAST & AFRICA: PERIPHERAL STENTS MARKET, BY TYPE,
2021–2023 (USD MILLION) 331
TABLE 545 REST OF MIDDLE EAST & AFRICA: PERIPHERAL STENTS MARKET, BY TYPE,
2024–2029 (USD MILLION) 332
TABLE 546 REST OF MIDDLE EAST & AFRICA: EVAR STENT GRAFTS MARKET, BY TYPE,
2021–2023 (USD MILLION) 332
TABLE 547 REST OF MIDDLE EAST & AFRICA: EVAR STENT GRAFTS MARKET, BY TYPE,
2024–2029 (USD MILLION) 332
TABLE 548 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 333
TABLE 549 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY TECHNOLOGY, 2024–2029 (USD MILLION) 333
TABLE 550 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2021–2023 (USD MILLION) 333
TABLE 551 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY MODE OF DELIVERY, 2024–2029 (USD MILLION) 334
TABLE 552 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY MATERIAL, 2021–2023 (USD MILLION) 334
TABLE 553 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY MATERIAL, 2024–2029 (USD MILLION) 334
TABLE 554 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION) 335
TABLE 555 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET FOR METALLIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION) 335
TABLE 556 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2021–2023 (USD MILLION) 335
TABLE 557 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET FOR POLYMERIC MATERIALS, BY TYPE, 2024–2029 (USD MILLION) 336
TABLE 558 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY END USER, 2021–2023 (USD MILLION) 336
TABLE 559 REST OF MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY END USER, 2024–2029 (USD MILLION) 336
TABLE 560 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES 337
TABLE 561 VASCULAR STENTS MARKET: DEGREE OF COMPETITION 340
TABLE 562 VASCULAR STENTS MARKET: TECHNOLOGY FOOTPRINT 345
TABLE 563 VASCULAR STENTS MARKET: PRODUCT FOOTPRINT 346
TABLE 564 VASCULAR STENTS MARKET: MODE OF DELIVERY FOOTPRINT 347
TABLE 565 VASCULAR STENTS MARKET: MATERIAL FOOTPRINT 348
TABLE 566 VASCULAR STENTS MARKET: END-USER FOOTPRINT 349
TABLE 567 VASCULAR STENTS MARKET: REGION FOOTPRINT 350
TABLE 568 VASCULAR STENTS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 353
TABLE 569 VASCULAR STENTS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY PRODUCT 353
TABLE 570 VASCULAR STENTS MARKET: PRODUCT L & APPROVALS,
JANUARY 2021–JULY 2024 356
TABLE 571 VASCULAR STENTS MARKET: DEALS, JANUARY 2021–JULY 2024 357
TABLE 572 VASCULAR STENTS MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JULY 2024 357
TABLE 573 MEDTRONIC PLC: COMPANY OVERVIEW 358
TABLE 574 MEDTRONIC PLC: PRODUCTS OFFERED 359
TABLE 575 MEDTRONIC PLC: PRODUCT APPROVALS, JANUARY 2021–JULY 2024 361
TABLE 576 ABBOTT LABORATORIES: COMPANY OVERVIEW 363
TABLE 577 ABBOTT LABORATORIES: PRODUCTS OFFERED 364
TABLE 578 ABBOTT LABORATORIES: DEALS, JANUARY 2021–JULY 2024 366
TABLE 579 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 367
TABLE 580 BOSTON SCIENTIFIC CORPORATION.: PRODUCTS OFFERED 368
TABLE 581 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2021–JULY 2024 370
TABLE 582 B. BRAUN SE: COMPANY OVERVIEW 372
TABLE 583 B. BRAUN SE: PRODUCTS OFFERED 373
TABLE 584 TERUMO CORPORATION: COMPANY OVERVIEW 375
TABLE 585 TERUMO CORPORATION: PRODUCTS OFFERED 376
TABLE 586 TERUMO CORPORATION: PRODUCT APPROVALS, JANUARY 2021–JULY 2024 378
TABLE 587 BIOTRONIK SE & CO. KG: COMPANY OVERVIEW 379
TABLE 588 BIOTRONIK SE & CO.KG.: PRODUCTS OFFERED 379
TABLE 589 SHANGHAI MICROPORT MEDICAL (GROUP) CO., LTD.: COMPANY OVERVIEW 380
TABLE 590 SHANGHAI MICROPORT MEDICAL (GROUP) CO., LTD.: PRODUCTS OFFERED 382
TABLE 591 SHANGHAI MICROPORT MEDICAL (GROUP) CO., LTD: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JULY 2024 384
TABLE 592 MERIL LIFE SCIENCES PVT. LTD.: COMPANY OVERVIEW 386
TABLE 593 MERIL LIFE SCIENCES PVT. LTD.: PRODUCTS OFFERED 386
TABLE 594 SAHAJANAND MEDICAL TECHNOLOGIES LIMITED: COMPANY OVERVIEW 388
TABLE 595 SAHAJANAND MEDICAL TECHNOLOGIES LIMITED: PRODUCTS OFFERED 388
TABLE 596 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 390
TABLE 597 BECTON, DICKINSON AND COMPANY.: PRODUCTS OFFERED 391
TABLE 598 W. L. GORE & ASSOCIATES, INC: COMPANY OVERVIEW 393
TABLE 599 W. L. GORE & ASSOCIATES, INC.: PRODUCTS OFFERED 393
TABLE 600 W. L. GORE & ASSOCIATES, INC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JULY 2024 394
TABLE 601 CORDIS CORPORATION: COMPANY OVERVIEW 395
TABLE 602 CORDIS CORPORATION: PRODUCTS OFFERED 395
TABLE 603 CORDIS CORPORATION: PRODUCT APPROVALS, JANUARY 2021–JULY 2024 396
TABLE 604 CORDIS CORPORATION: OTHER DEVELOPMENTS, JANUARY 2021–JULY 2024 396
TABLE 605 ARTIVION, INC.: COMPANY OVERVIEW 397
TABLE 606 ARTIVION, INC.: PRODUCTS OFFERED 398
TABLE 607 ARTIVION, INC.: OTHER DEVELOPMENTS, JANUARY 2021–JULY 2024 399
TABLE 608 STRYKER CORPORATION.: COMPANY OVERVIEW 400
TABLE 609 STRYKER CORPORATION.: PRODUCTS OFFERED 401
TABLE 610 LIFETECH SCIENTIFIC CORPORATION.: COMPANY OVERVIEW 402
TABLE 611 LIFETECH SCIENTIFIC CORPORATION: PRODUCTS OFFERED 403
TABLE 612 TRANSLUMINA: COMPANY OVERVIEW 404
TABLE 613 TRANSLUMINA: PRODUCTS OFFERED 404
TABLE 614 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY OVERVIEW 406
TABLE 615 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: PRODUCTS OFFERED 407
TABLE 616 ENDOLOGIX LLC.: COMPANY OVERVIEW 408
TABLE 617 ENDOLOGIX LLC.PRODUCTS OFFERED 408
TABLE 618 BIOSENSORS INTERNATIONAL GROUP, LTD.: COMPANY OVERVIEW 409
TABLE 619 BIOSENSORS INTERNATIONAL GROUP, LTD.: PRODUCTS OFFERED 409
TABLE 620 BIOSENSORS INTERNATIONAL GROUP, LTD.: PRODUCT APPROVALS, JANUARY 2021–JULY 2024 410
LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN 42
FIGURE 2 PRIMARY SOURCES 45
FIGURE 3 PRIMARY BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 47
FIGURE 4 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 48
FIGURE 5 TOP-DOWN APPROACH 49
FIGURE 6 MARKET SIZE ESTIMATION: DEMAND-SIDE ASSESSMENT 50
FIGURE 7 IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES (2024–2029) 51
FIGURE 8 VASCULAR STENTS MARKET: CAGR PROJECTIONS 52
FIGURE 9 DATA TRIANGULATION METHODOLOGY 53
FIGURE 10 VASCULAR STENTS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION) 56
FIGURE 11 VASCULAR STENTS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION) 57
FIGURE 12 PERIPHERAL STENTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 57
FIGURE 13 EVAR STENT GRAFTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 58
FIGURE 14 VASCULAR STENTS MARKET, BY MODE OF DELIVERY,
2024 VS. 2029 (USD MILLION) 59
FIGURE 15 VASCULAR STENTS MARKET, BY MATERIAL, 2024 VS. 2029 (USD MILLION) 59
FIGURE 16 VASCULAR STENTS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 60
FIGURE 17 VASCULAR STENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 61
FIGURE 18 RISING PREVALENCE OF VASCULAR DISEASES AND SUBSEQUENT RISE IN ANGIOPLASTY PROCEDURES TO PROPEL MARKET 62
FIGURE 19 CORONARY STENTS SEGMENT ACCOUNTED FOR LARGEST
MARKET SHARE IN US (2023) 63
FIGURE 20 EMERGING MARKETS TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 64
FIGURE 21 ASIA PACIFIC REGION TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 65
FIGURE 22 VASCULAR STENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 66
FIGURE 23 NUMBER OF PATENTS PUBLISHED (JANUARY 2014─MARCH 2024) 83
FIGURE 24 TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR VASCULAR STENTS
PATENTS (JANUARY 2014−JULY 2024) 84
FIGURE 25 TOP APPLICANT COUNTRIES/REGIONS FOR VASCULAR STENTS
(JANUARY 2014− JULY 2024) 84
FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VASCULAR STENTS 89
FIGURE 27 KEY BUYING CRITERIA FOR VASCULAR STENTS 89
FIGURE 28 VASCULAR STENTS MARKET: ECOSYSTEM ANALYSIS 92
FIGURE 29 VASCULAR STENTS MARKET: SUPPLY CHAIN ANALYSIS 96
FIGURE 30 REVENUE SHIFT FOR VASCULAR STENTS MARKET 97
FIGURE 31 VASCULAR STENTS MARKET: INVESTMENT AND FUNDING SCENARIO (2018–2022) 98
FIGURE 32 INTERVENTIONAL CARDIOLOGY DEVICES: MARKET OVERVIEW 99
FIGURE 33 NORTH AMERICA: VASCULAR STENTS MARKET SNAPSHOT 173
FIGURE 34 ASIA PACIFIC: VASCULAR STENTS MARKET SNAPSHOT 242
FIGURE 35 REVENUE ANALYSIS OF KEY PLAYERS IN VASCULAR STENTS MARKET
(2021–2023) 339
FIGURE 36 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VASCULAR STENTS MARKET (2023) 340
FIGURE 37 RANKING OF KEY PLAYERS IN VASCULAR STENTS MARKET, 2023 341
FIGURE 38 VASCULAR STENTS MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2023 343
FIGURE 39 VASCULAR STENTS MARKET: COMPANY FOOTPRINT 344
FIGURE 40 VASCULAR STENTS MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2023 352
FIGURE 41 EV/EBITDA OF KEY VENDORS 354
FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 354
FIGURE 43 VASCULAR STENTS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 355
FIGURE 44 MEDTRONIC PLC: COMPANY SNAPSHOT (2023) 359
FIGURE 45 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2023) 364
FIGURE 46 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023) 368
FIGURE 47 B. BRAUN SE: COMPANY SNAPSHOT (2023) 373
FIGURE 48 TERUMO CORPORATION: COMPANY SNAPSHOT (2023) 376
FIGURE 49 SHANGHAI MICROPORT MEDICAL (GROUP) CO., LTD.: COMPANY SNAPSHOT (2023) 381
FIGURE 50 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2023) 391
FIGURE 51 ARTIVION, INC.: COMPANY SNAPSHOT (2023) 398
FIGURE 52 STRYKER CORPORATION: COMPANY SNAPSHOT (2023) 401
FIGURE 53 LIFETECH SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023) 403
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11